Reduce suffering using EEG biomarkers


Amourie Prentice

Works on PhD at Research Institute Brainclinics, since October 2020

How did you get into neuropsychology?
I received my Bachelor degree in Psychology from the Université libre de Bruxelles in July 2019, and my MSc in Neuropsychology from Maastricht University in August 2020.
It was during my ERASMUS exchange program (2018) with the University of Toronto that I discovered my passion for neuropsychology. I returned to Toronto for a summer internship in Dr. Randy McIntosh’s lab, who specialises in Partial Least Squares analysis in order to characterize brain network dynamics.
I did my master internship in Dr. Donna Rose Addis’s lab in Toronto, who specializes in characterizing the processes of memory and imagination. The topic for my master thesis was determining whether performance and whole brain functional activity for emotion recognition differs between young and older adults through analysis of fMRI data.

Why Brainclinics?
When I heard how Brainclinics focuses on determining through EEG biomarkers which treatment would be most effective for patients, I had to jump onboard. I believe we should never forget that a patient is an individual and therefore a treatment for one may not help another. To be able to assess which treatment would work at an early stage will save time, money, and suffering. My current research revolves around finding QEEG biomarkers in patients with depression that will predict a positive response to psychotherapy.